4.8 Article

Somatic reversion of pathogenic DOCK8 variants alters lymphocyte differentiation and function to effectively cure DOCK8 deficiency

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 131, Issue 3, Pages -

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI142434

Keywords

-

Funding

  1. National Health and Medical Research Council (NHMRC) of Australia [1060303, 1088215, 1127157, 1139865]
  2. Office of Health and Medical Research of the New South Wales government
  3. Jeffrey Modell Foundation
  4. John Brown Cook Foundation
  5. Centre de Reference Deficits Immunitaires Hereditaires (CEREDIH)
  6. ERA-Net for Research Programmes on Rare Diseases (E-Rare: EuroCID) [ANR RANR187, 061-2016-050]
  7. Research Training Program Scholarship - Australian government
  8. NHMRC Leadership 3 Investigator grant
  9. Early-Mid Career Research Fellowship from the New South Wales government
  10. NHMRC [1042925]
  11. National Health and Medical Research Council of Australia [1088215, 1127157, 1139865, 1060303] Funding Source: NHMRC

Ask authors/readers for more resources

Inborn errors of immunity can lead to monogenic immune dysregulatory conditions, and somatic reversion can improve clinical symptoms, including complete resolution of infections and allergic diseases. Acquisition of DOCK8 expression can restore lymphocyte signaling and cell function, which is significant for the treatment of DOCK8 deficiency.
Inborn errors of immunity cause monogenic immune dysregulatory conditions such as severe and recurrent pathogen infection, inflammation, allergy, and malignancy. Somatic reversion refers to the spontaneous repair of a pathogenic germline genetic variant and has been reported to occur in a number of inborn errors of immunity, with a range of impacts on clinical outcomes of these conditions. DOCK8 deficiency due to biallelic inactivating mutations in DOCK8 causes a combined immunodeficiency characterized by severe bacterial, viral, and fungal infections, as well as allergic disease and some cancers. Here, we describe the clinical, genetic, and cellular features of 3 patients with biallelic DOCK8 variants who, following somatic reversion in multiple lymphocyte subsets, exhibited improved clinical features, including complete resolution of infection and allergic disease, and cure over time. Acquisition of DOCK8 expression restored defective lymphocyte signalling, survival and proliferation, as well as CD8(+) T cell cytotoxicity, CD4(+) T cell cytokine production, and memory B cell generation compared with typical DOCK8-deficient patients. Our temporal analysis of DOCK8-revertant and DOCK8-deficient cells within the same individual established mechanisms of clinical improvement in these patients following somatic reversion and revealed further nonredundant functions of DOCK8 in human lymphocyte biology. Last, our findings have significant implications for future therapeutic options for the treatment of DOCKS deficiency.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available